Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
- Status
- COMPLETED
- Phase
- N/A
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial
- Status
- COMPLETED
- Phase
- N/A
Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Early Ageing During Therapy in AYA Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
- Status
- COMPLETED
- Phase
- N/A
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Survey Exploring Health and Screening Tests in People Treated for Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Lung Screening in People Cured of Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Prognostic Value Of Lymphocyte Count and Lymphocyte/ Monocyte Ratio in Patients With Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Methods of T Cell Depletion Trial (MoTD)
- Status
- RECRUITING
- Phase
- PHASE2
Radiation Free Chemotherapy for Early Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT
- Status
- UNKNOWN
- Phase
- PHASE2